A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
A Phase II Randomized,Controlled,Open Label,Multicentre Study to evaluate the efficacy and safety of Tegafur combined with Temozolomide versus Tegafur combined with Temozolomide and Thalidomide in subjects with Advanced Pancreatic Neuroendocrine Tumor
Epistemonikos ID: 727b2bf8e741e8775863bea95882e5f24cc28a79
First added on: May 20, 2024